Atacicept
Atacicept (TACI-Ig) is a is a recombinant fusion protein containing the extracellular, ligand-binding portion of the TACI receptor and the Fc portion of human IgG. Atacicept inhibits B cell stimulation by binding to B lymphocyte stimulator and a proliferation-inducing ligand. Atacicept can be used in research of B-cell autoimmune disease[1][2].
Product Specifications
CAS Number
845264-92-8
Product Name Alternative
TACI-Ig; TACI-Fc 5
UNSPSC
12352203
Target
TNF Receptor
Type
Inhibitory Antibodies
Related Pathways
Apoptosis
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/atacicept.html
Purity
99.5
Solubility
10 mM in DMSO
Smiles
[Atacicept]
Molecular Weight
(70.45 kDa)
References & Citations
[1]Gross JA, et, al. TACI-Ig neutralizes molecules critical for B cell development and autoimmune disease. impaired B cell maturation in mice lacking BLyS. Immunity. 2001 Aug;15 (2) :289-302. |[2]Gross JA, et, al. TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease. Nature. 2000 Apr 27;404 (6781) :995-9.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 3
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
bsm-52163R-BF350-TR 20 µL
Phospho-H2AX (Ser139) Recombinant Antibody, AbBy Fluor™ 350 Conjugated
Sign In for Pricing
View Details 
MBS2705023-01 24 Strip Well
Rat Cytochrome P450 1A1 (CYP1A1) ELISA Kit
Sign In for Pricing
View Details